Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Immunogenicity of a recombinant fusion construct composed of intrinsically unstructured, low polymorphic segments derived from merozoite surface protein 2 and trophozoite exported protein 1.

Tiendrebeogo RW, Spallek R, Oehlmann W, Singh M, Theisen M, Nebie I, Moret R, Roussilhon C, Corradin G.

Vaccine. 2019 Aug 23;37(36):5332-5340. doi: 10.1016/j.vaccine.2019.07.048. Epub 2019 Jul 26.

PMID:
31358409
2.

Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection.

Hart P, Copland A, Diogo GR, Harris S, Spallek R, Oehlmann W, Singh M, Basile J, Rottenberg M, Paul MJ, Reljic R.

Mol Ther. 2018 Mar 7;26(3):822-833. doi: 10.1016/j.ymthe.2017.12.016. Epub 2017 Dec 22.

3.

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis.

Aguilo N, Gonzalo-Asensio J, Alvarez-Arguedas S, Marinova D, Gomez AB, Uranga S, Spallek R, Singh M, Audran R, Spertini F, Martin C.

Nat Commun. 2017 Jul 14;8:16085. doi: 10.1038/ncomms16085.

4.

Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.

Grünwald B, Harant V, Schaten S, Frühschütz M, Spallek R, Höchst B, Stutzer K, Berchtold S, Erkan M, Prokopchuk O, Martignoni M, Esposito I, Heikenwalder M, Gupta A, Siveke J, Saftig P, Knolle P, Wohlleber D, Krüger A.

Gastroenterology. 2016 Nov;151(5):1011-1024.e7. doi: 10.1053/j.gastro.2016.07.043. Epub 2016 Aug 6.

PMID:
27506299
5.

A Sero-epidemiological Approach to Explore Transmission of Mycobacterium ulcerans.

Ampah KA, Nickel B, Asare P, Ross A, De-Graft D, Kerber S, Spallek R, Singh M, Pluschke G, Yeboah-Manu D, Röltgen K.

PLoS Negl Trop Dis. 2016 Jan 25;10(1):e0004387. doi: 10.1371/journal.pntd.0004387. eCollection 2016 Jan.

6.

A Subgroup of Latently Mycobacterium tuberculosis Infected Individuals Is Characterized by Consistently Elevated IgA Responses to Several Mycobacterial Antigens.

Baumann R, Kaempfer S, Chegou NN, Oehlmann W, Spallek R, Loxton AG, van Helden PD, Black GF, Singh M, Walzl G.

Mediators Inflamm. 2015;2015:364758. doi: 10.1155/2015/364758. Epub 2015 Aug 10.

7.

Identification and evaluation of new Mycobacterium bovis antigens in the in vitro interferon gamma release assay for bovine tuberculosis diagnosis.

Eirin ME, Macias A, Magnano G, Morsella C, Mendez L, Blanco FC, Bianco MV, Severina W, Alito A, Pando MLA, Singh M, Spallek R, Paolicchi FA, Bigi F, Cataldi AA.

Tuberculosis (Edinb). 2015 Dec;95(6):795-801. doi: 10.1016/j.tube.2015.07.009. Epub 2015 Aug 8.

PMID:
26320985
8.

Structures of citrate synthase and malate dehydrogenase of Mycobacterium tuberculosis.

Ferraris DM, Spallek R, Oehlmann W, Singh M, Rizzi M.

Proteins. 2015 Feb;83(2):389-94. doi: 10.1002/prot.24743. Epub 2015 Jan 7.

PMID:
25524525
9.

Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B.

Fuchs M, Kämpfer S, Helmsing S, Spallek R, Oehlmann W, Prilop W, Frank R, Dübel S, Singh M, Hust M.

BMC Biotechnol. 2014 Jul 17;14:68. doi: 10.1186/1472-6750-14-68.

10.

Crystal structure of the Mycobacterium tuberculosis phosphate binding protein PstS3.

Ferraris DM, Spallek R, Oehlmann W, Singh M, Rizzi M.

Proteins. 2014 Sep;82(9):2268-74. doi: 10.1002/prot.24548. Epub 2014 Mar 24.

PMID:
24615888
11.

Serodiagnostic markers for the prediction of the outcome of intensive phase tuberculosis therapy.

Baumann R, Kaempfer S, Chegou NN, Nene NF, Veenstra H, Spallek R, Bolliger CT, Lukey PT, van Helden PD, Singh M, Walzl G.

Tuberculosis (Edinb). 2013 Mar;93(2):239-45. doi: 10.1016/j.tube.2012.09.003. Epub 2012 Nov 2.

PMID:
23127778
12.

Microbial heat shock protein 65 attenuates airway hyperresponsiveness and inflammation by modulating the function of dendritic cells.

Shin YS, Takeda K, Shiraishi Y, Jeong YY, Domenico J, Jia Y, Han J, Spallek R, Singh M, Lucas JJ, Gelfand EW.

J Immunol. 2012 Oct 1;189(7):3404-10. Epub 2012 Aug 29.

13.

Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques.

Yang GB, Wang Y, Babaahmady K, Schøller J, Rahman D, Bunnik E, Spallek R, Zong CM, Duan JZ, Qin C, Jiang H, Singh M, Vaughan R, Bergmeier LA, Schuitemaker H, Shao Y, Lehner T.

J Gen Virol. 2012 Jul;93(Pt 7):1506-18. doi: 10.1099/vir.0.041061-0. Epub 2012 Apr 4.

PMID:
22492918
14.

The Mycobacterium tuberculosis Ag85A is a novel diacylglycerol acyltransferase involved in lipid body formation.

Elamin AA, Stehr M, Spallek R, Rohde M, Singh M.

Mol Microbiol. 2011 Sep;81(6):1577-92. doi: 10.1111/j.1365-2958.2011.07792.x. Epub 2011 Aug 23.

15.

The M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infection.

Palma C, Spallek R, Piccaro G, Pardini M, Jonas F, Oehlmann W, Singh M, Cassone A.

Clin Dev Immunol. 2011;2011:690328. doi: 10.1155/2011/690328. Epub 2011 Mar 27.

16.

Non-acylated Mycobacterium bovis glycoprotein MPB83 binds to TLR1/2 and stimulates production of matrix metalloproteinase 9.

Chambers MA, Whelan AO, Spallek R, Singh M, Coddeville B, Guerardel Y, Elass E.

Biochem Biophys Res Commun. 2010 Sep 24;400(3):403-8. doi: 10.1016/j.bbrc.2010.08.085. Epub 2010 Aug 26.

PMID:
20800577
17.

Cardiovascular risk factors and atherosclerosis in young women: atherosclerosis risk factors in female youngsters (ARFY study).

Knoflach M, Kiechl S, Penz D, Zangerle A, Schmidauer C, Rossmann A, Shingh M, Spallek R, Griesmacher A, Bernhard D, Robatscher P, Buchberger W, Draxl W, Willeit J, Wick G.

Stroke. 2009 Apr;40(4):1063-9. doi: 10.1161/STROKEAHA.108.525675. Epub 2009 Feb 10.

PMID:
19211497
18.

Serodiagnosis of tuberculosis: specific detection of free and complex-dissociated antibodies anti-mycobacterium tuberculosis recombinant antigens.

Imaz MS, Schmelling MF, Kaempfer S, Spallek R, Singh M.

Braz J Infect Dis. 2008 Jun;12(3):234-44.

PMID:
18833409
19.

Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen.

Klucar P, Barnes PF, Kong Y, Samten B, Tvinnereim A, Spallek R, Nepom GT, Singh M, Shams H.

Hum Immunol. 2008 Aug;69(8):475-83. doi: 10.1016/j.humimm.2008.05.008. Epub 2008 Jun 25.

PMID:
18588932
20.

The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays.

Vilaplana C, Ruiz-Manzano J, Gil O, Cuchillo F, Montané E, Singh M, Spallek R, Ausina V, Cardona PJ.

Scand J Immunol. 2008 Jun;67(6):610-7. doi: 10.1111/j.1365-3083.2008.02103.x. Epub 2008 Apr 4.

21.

Identification of novel bacterial plasminogen-binding proteins in the human pathogen Mycobacterium tuberculosis.

Xolalpa W, Vallecillo AJ, Lara M, Mendoza-Hernandez G, Comini M, Spallek R, Singh M, Espitia C.

Proteomics. 2007 Sep;7(18):3332-41.

PMID:
17849409
22.
23.

Antibodies against C-reactive protein cross-react with 60-kilodalton heat shock proteins.

Udvarnoki K, Cervenak L, Uray K, Hudecz F, Kacskovics I, Spallek R, Singh M, Füst G, Prohászka Z.

Clin Vaccine Immunol. 2007 Apr;14(4):335-41. Epub 2007 Feb 14.

24.

[In-vitro comparison of morphology of current microkeratomes for LASIK].

Schäfer S, Spallek R, Russ D, Pohl T, Lang GK, Kampmeier J.

Klin Monbl Augenheilkd. 2005 Aug;222(8):615-22. German.

PMID:
16118741
25.

Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals.

Bulut Y, Michelsen KS, Hayrapetian L, Naiki Y, Spallek R, Singh M, Arditi M.

J Biol Chem. 2005 Jun 3;280(22):20961-7. Epub 2005 Apr 4.

26.

Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer.

Sänger C, Busche A, Bentien G, Spallek R, Jonas F, Böhle A, Singh M, Brandau S.

BMC Cancer. 2004 Nov 26;4:86.

27.

The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection.

Lehner T, Mitchell E, Bergmeier L, Singh M, Spallek R, Cranage M, Hall G, Dennis M, Villinger F, Wang Y.

Eur J Immunol. 2000 Aug;30(8):2245-56.

28.

Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy.

Dieli F, Singh M, Spallek R, Romano A, Titone L, Sireci G, Friscia G, Di Sano C, Santini D, Salerno A, Ivanyi J.

Scand J Immunol. 2000 Jul;52(1):96-102.

29.

Cloning and expression of tryparedoxin I from Crithidia fasciculata.

Guerrero SA, Montemartini M, Spallek R, Hecht HJ, Steinert P, Flohé L, Singh M.

Biofactors. 2000;11(1-2):67-9. No abstract available.

PMID:
10705964
30.

Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity.

Lehner T, Bergmeier LA, Wang Y, Tao L, Sing M, Spallek R, van der Zee R.

Eur J Immunol. 2000 Feb;30(2):594-603.

31.

Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis.

Tanaka S, Kimura Y, Mitani A, Yamamoto G, Nishimura H, Spallek R, Singh M, Noguchi T, Yoshikai Y.

J Immunol. 1999 Nov 15;163(10):5560-5.

32.

Broad clonal heterogeneity of antigen-specific CD4+ T-cells localizing at the site of disease during tuberculosis.

Dieli F, Sireci G, Ivanyi J, Singh M, Friscia G, Di Sano C, Spallek R, Salerno A.

Immunol Lett. 1999 Sep 1;69(3):311-5.

PMID:
10528794
33.

Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy.

Dieli F, Friscia G, Di Sano C, Ivanyi J, Singh M, Spallek R, Sireci G, Titone L, Salerno A.

J Infect Dis. 1999 Jul;180(1):225-8.

PMID:
10353886

Supplemental Content

Loading ...
Support Center